GeneDx Holdings Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US81663L2007
USD
161.95
1.35 (0.84%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About GeneDx Holdings Corp. stock-summary
stock-summary
GeneDx Holdings Corp.
Pharmaceuticals & Biotechnology
CM Life Sciences, Inc. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an initial business combination target in any industry, sector or geographic region, it intends to focus its efforts on the life sciences sector. The Company has not conducted any operations and has not generated any revenues.
Company Coordinates stock-summary
Company Details
C/O Corvex Management Lp, 667 Madison Avenue NEW YORK NY : 10020
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 63 Schemes (32.01%)

Foreign Institutions

Held by 85 Foreign Institutions (7.54%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
103 Million
(Quarterly Results - Jun 2025)
Net Profit:
11 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 3,715 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.28

stock-summary
Return on Equity

1.62%

stock-summary
Price to Book

13.41